Genoray Co. Ltd (122310) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.008x

Based on the latest financial reports, Genoray Co. Ltd (122310) has a cash flow conversion efficiency ratio of 0.008x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩639.06 Million ≈ $433.08K USD) by net assets (₩77.26 Billion ≈ $52.36 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Genoray Co. Ltd - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how Genoray Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Genoray Co. Ltd (122310) financial obligations for a breakdown of total debt and financial obligations.

Genoray Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Genoray Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Covalon Technologies Ltd. V:COV	-0.022x
Jinli Group Holdings Ltd TW:8429	0.001x
Ascent Solar Technologies, Inc. Common Stock NASDAQ:ASTI	-0.541x
Kafein Yazilim IS:KFEIN	0.024x
Corem Property Group AB (publ) ST:CORE-A	0.015x
Mentice AB ST:MNTC	-0.086x
Caprice Resources Ltd AU:CRS	-0.023x
Ihuman Inc NYSE:IH	0.193x

Annual Cash Flow Conversion Efficiency for Genoray Co. Ltd (2015–2024)

The table below shows the annual cash flow conversion efficiency of Genoray Co. Ltd from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see 122310 market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩85.89 Billion ≈ $58.21 Million	₩13.27 Billion ≈ $9.00 Million	0.155x	+315.37%
2023-12-31	₩95.53 Billion ≈ $64.74 Million	₩3.55 Billion ≈ $2.41 Million	0.037x	-77.94%
2022-12-31	₩87.96 Billion ≈ $59.61 Million	₩14.84 Billion ≈ $10.05 Million	0.169x	-13.58%
2021-12-31	₩78.82 Billion ≈ $53.41 Million	₩15.38 Billion ≈ $10.43 Million	0.195x	+52.63%
2020-12-31	₩66.53 Billion ≈ $45.08 Million	₩8.51 Billion ≈ $5.77 Million	0.128x	-28.49%
2019-12-31	₩59.59 Billion ≈ $40.38 Million	₩10.65 Billion ≈ $7.22 Million	0.179x	+16.67%
2018-12-31	₩44.97 Billion ≈ $30.48 Million	₩6.89 Billion ≈ $4.67 Million	0.153x	-16.72%
2017-12-31	₩24.30 Billion ≈ $16.47 Million	₩4.47 Billion ≈ $3.03 Million	0.184x	-21.57%
2016-12-31	₩14.80 Billion ≈ $10.03 Million	₩3.47 Billion ≈ $2.35 Million	0.235x	+26.88%
2015-12-31	₩11.35 Billion ≈ $7.69 Million	₩2.10 Billion ≈ $1.42 Million	0.185x	--

About Genoray Co. Ltd

KQ:122310 Korea Diagnostics & Research

Market Cap

$38.45 Million

₩56.74 Billion KRW

Market Cap Rank

#22822 Global

#1576 in Korea

Share Price

₩4620.00

Change (1 day)

-2.63%

52-Week Range

₩3810.00 - ₩5910.00

All Time High

₩11740.92